341 related articles for article (PubMed ID: 8626530)
1. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.
Pronk GJ; de Vries-Smits AM; Buday L; Downward J; Maassen JA; Medema RH; Bos JL
Mol Cell Biol; 1994 Mar; 14(3):1575-81. PubMed ID: 8114695
[TBL] [Abstract][Full Text] [Related]
3. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
[TBL] [Abstract][Full Text] [Related]
5. The signaling pathway coupling epidermal growth factor receptors to activation of p21ras.
Sasaoka T; Langlois WJ; Leitner JW; Draznin B; Olefsky JM
J Biol Chem; 1994 Dec; 269(51):32621-5. PubMed ID: 7798267
[TBL] [Abstract][Full Text] [Related]
6. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
7. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
8. Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.
Tauchi T; Boswell HS; Leibowitz D; Broxmeyer HE
J Exp Med; 1994 Jan; 179(1):167-75. PubMed ID: 7505797
[TBL] [Abstract][Full Text] [Related]
9. Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation.
Waters SB; Chen D; Kao AW; Okada S; Holt KH; Pessin JE
J Biol Chem; 1996 Jul; 271(30):18224-30. PubMed ID: 8663461
[TBL] [Abstract][Full Text] [Related]
10. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts.
Haugh JM; Huang AC; Wiley HS; Wells A; Lauffenburger DA
J Biol Chem; 1999 Nov; 274(48):34350-60. PubMed ID: 10567412
[TBL] [Abstract][Full Text] [Related]
11. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.
Smit L; van der Horst G; Borst J
J Biol Chem; 1996 Apr; 271(15):8564-9. PubMed ID: 8621483
[TBL] [Abstract][Full Text] [Related]
12. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
13. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex.
Holt KH; Waters SB; Okada S; Yamauchi K; Decker SJ; Saltiel AR; Motto DG; Koretzky GA; Pessin JE
J Biol Chem; 1996 Apr; 271(14):8300-6. PubMed ID: 8626525
[TBL] [Abstract][Full Text] [Related]
15. Carbachol activates ERK2 in isolated gastric parietal cells via multiple signaling pathways.
Takeuchi Y; Pausawasdi N; Todisco A
Am J Physiol; 1999 Jun; 276(6):G1484-92. PubMed ID: 10362652
[TBL] [Abstract][Full Text] [Related]
16. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.
Curto M; Frankel P; Carrero A; Foster DA
Biochem Biophys Res Commun; 1998 Feb; 243(2):555-60. PubMed ID: 9480847
[TBL] [Abstract][Full Text] [Related]
17. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes.
Harmer SL; DeFranco AL
Mol Cell Biol; 1997 Jul; 17(7):4087-95. PubMed ID: 9199344
[TBL] [Abstract][Full Text] [Related]
18. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
19. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway.
Prigent SA; Nagane M; Lin H; Huvar I; Boss GR; Feramisco JR; Cavenee WK; Huang HS
J Biol Chem; 1996 Oct; 271(41):25639-45. PubMed ID: 8810340
[TBL] [Abstract][Full Text] [Related]
20. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
Smit L; van der Horst G; Borst J
Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]